Business Description
AbbVie Inc
NAICS : 325412
SIC : 5122
ISIN : US00287Y1091
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.04 | |||||
Debt-to-Equity | 11.78 | |||||
Debt-to-EBITDA | 3.9 | |||||
Interest Coverage | 5.43 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.83 | |||||
Beneish M-Score | -2.68 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.8 | |||||
3-Year EBITDA Growth Rate | 9.6 | |||||
3-Year EPS without NRI Growth Rate | 1.7 | |||||
3-Year FCF Growth Rate | 7.4 | |||||
3-Year Book Growth Rate | -7.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 7.74 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.5 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.92 | |||||
9-Day RSI | 39.66 | |||||
14-Day RSI | 40.76 | |||||
6-1 Month Momentum % | 17.09 | |||||
12-1 Month Momentum % | 38.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.65 | |||||
Quick Ratio | 0.54 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 84.15 | |||||
Days Sales Outstanding | 75.86 | |||||
Days Payable | 73.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.24 | |||||
Dividend Payout Ratio | 0.57 | |||||
3-Year Dividend Growth Rate | 7.8 | |||||
Forward Dividend Yield % | 3.76 | |||||
5-Year Yield-on-Cost % | 5.21 | |||||
Shareholder Yield % | 1.66 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.21 | |||||
Operating Margin % | 26.13 | |||||
Net Margin % | 9.22 | |||||
FCF Margin % | 28.18 | |||||
ROE % | 59.19 | |||||
ROA % | 3.63 | |||||
ROIC % | 8.83 | |||||
ROC (Joel Greenblatt) % | 196.81 | |||||
ROCE % | 9.75 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 63.85 | |||||
Forward PE Ratio | 14.24 | |||||
PE Ratio without NRI | 17.1 | |||||
Shiller PE Ratio | 38.52 | |||||
Price-to-Owner-Earnings | 36.04 | |||||
PEG Ratio | 1.1 | |||||
PS Ratio | 5.87 | |||||
PB Ratio | 53.86 | |||||
Price-to-Free-Cash-Flow | 20.87 | |||||
Price-to-Operating-Cash-Flow | 19.75 | |||||
EV-to-EBIT | 38.9 | |||||
EV-to-Forward-EBIT | 13.83 | |||||
EV-to-EBITDA | 21.06 | |||||
EV-to-Forward-EBITDA | 13.34 | |||||
EV-to-Revenue | 6.92 | |||||
EV-to-Forward-Revenue | 6.42 | |||||
EV-to-FCF | 24.26 | |||||
Price-to-Projected-FCF | 1.65 | |||||
Price-to-DCF (Earnings Based) | 0.67 | |||||
Price-to-DCF (FCF Based) | 0.74 | |||||
Price-to-Median-PS-Value | 1.34 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.7 | |||||
Earnings Yield (Greenblatt) % | 2.57 | |||||
FCF Yield % | 4.84 | |||||
Forward Rate of Return (Yacktman) % | 16.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AbbVie Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 998,795.689 | ||
EPS (TTM) (MXN) | 52.076 | ||
Beta | 0.03 | ||
Volatility % | 25.96 | ||
14-Day RSI | 40.76 | ||
14-Day ATR (MXN) | 39.765205 | ||
20-Day SMA (MXN) | 3596.5105 | ||
12-1 Month Momentum % | 38.14 | ||
52-Week Range (MXN) | 2612.9 - 4080.5 | ||
Shares Outstanding (Mil) | 1,767.14 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AbbVie Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AbbVie Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
AbbVie Inc Frequently Asked Questions
What is AbbVie Inc(MEX:ABBV)'s stock price today?
When is next earnings date of AbbVie Inc(MEX:ABBV)?
Does AbbVie Inc(MEX:ABBV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |